ICARES Medicus, Inc.
TWO: 6612.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Tan-Li Chen
- Employees
- 77
- Headquarters
- Zhubei, Taiwan
- IPO year
- 2016
- Market cap
- NT$3.2B
- Website
- https://www.icaresmedicus.com
Loading 6612…
Loading profile data…Frequently asked questions about 6612
What does ICARES Medicus, Inc. (6612.TWO) do?
ICARES Medicus, Inc., a nano-medical material company, focuses on the research and development, manufacture, and sale of ophthalmic medical materials in Taiwan and internationally. It provides ophthalmic medical materials, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, or astigmatism; and surgical implan...
Where does 6612.TWO trade?
ICARES Medicus, Inc. (6612.TWO) trades on the Taipei Exchange.
What sector is 6612.TWO in?
ICARES Medicus, Inc. (6612.TWO) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of ICARES Medicus, Inc.?
Tan-Li Chen is the chief executive officer of ICARES Medicus, Inc. (6612.TWO).
Where is ICARES Medicus, Inc. headquartered?
ICARES Medicus, Inc. is headquartered in Taiwan.
Does 6612.TWO pay a dividend?
Yes — ICARES Medicus, Inc. (6612.TWO) paid a trailing twelve-month dividend of TWD 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6612.TWO go public?
ICARES Medicus, Inc. (6612.TWO) completed its initial public offering in 2016.